FLUORSID ANNOUNCES AGREEMENT TO SELL ITS CONTROLLED COMPANY ALKEEMIA SPA TO FUNDS MANAGED BY BLANTYRE CAPITAL

FLUORSID announces today the sale of its portfolio company Alkeemia Spa and the related assets, including the plant in Porto Marghera in Italy and the 50% participation in CF Carbons in Germany, to funds managed by Blantyre Capital Limited. The sale is part of a broader strategy, aimed to focus the operations of the company towards its core expertise within the fluorochemicals for the aluminium industry, in which FLUORSID has built a proven track record of more than 50 years and today operates as world leader. Alkeemia is one of the main producers of anhydrous hydrogen fluoride (AHF) in Europe. Blantyre Capital recognises the company’s leading position and potential, together with its strong management expertise, and believes the company is uniquely positioned to continue its growth investment plans. The closing has been signed today implying that FLUORSID and Blantyre Capital will ensure an orderly transition of ownership, allowing the preservation of jobs and the continuing delivery of existing services to Alkeemia’s customers whilst complying with the highest safety and environmental standards. About Blantyre Capital Blantyre Capital (“Blantyre”) is a London-based investment management firm that was founded in 2016 by Mubashir Mukadam who was previously Head of European Special Situations at KKR. The Blantyre team invests in situations across various jurisdictions, employing a full spectrum of strategies in respect of its investment partners, including providing direct financing, repairing capital structures, and seeking to improve operations. The firm is focused on supporting their investment partners through periods of transition and providing flexible capital. Blantyre manages long-term committed capital in excess of EUR1.6bn on behalf of highly regarded institutional investors including public and private pension plans, endowments, foundations, private funds and family offices. Blantyre endeavours to be the leading middle market special situations partner of choice for its investors and investment partners by helping to transform businesses globally.